Stack logic. Interaction data. Cycle structure. No guesswork.
A reference for people designing peptide stacks — combination data, interaction profiles, cycle structure, and planning logic. Independent. No supplements sold. No protocols endorsed.
Which peptides are documented in combination, what synergies are proposed, and where co-administration data is absent.
Known interactions between compounds — from documented additive effects to flagged contraindications and competition pathways.
How experienced users structure peptide cycles — timing, sequencing, on/off periods, and what the research suggests about cycle length.
How dosing changes in a stack context — adjustments, timing windows, and administration route considerations when combining compounds.
Selank has a notably clean interaction profile — no documented pharmacokinetic conflicts with commonly co-administered peptides. The interaction cautions that do exist relate to pharmacodynamic overlap: stacking Selank with other anxiolytic compounds risks additive CNS depression, and combining with stimulating peptides like Semax requires careful dose management.
A 12-week recovery cycle typically structures weeks 1–6 as a loading phase with higher-frequency administration, weeks 7–10 as a consolidation phase at reduced frequency, and weeks 11–12 as a taper. The specific peptide determines whether loading makes pharmacological sense — not all peptides have a loading rationale.
BPC-157 and TB-500 are the most commonly co-administered peptides in recovery protocols and no adverse interactions have been reported in either animal studies or user reports. Their mechanisms are complementary — BPC-157 addresses inflammatory signalling, TB-500 promotes cell migration — but no co-administration RCT exists.
Additive tissue repair signalling in rodent co-administration studies. BPC-157 and TB-500 share overlapping regenerative pathways — together they show enhanced angiogenesis and recovery markers compared to either compound alone.
Mechanistic extrapolation — no controlled human co-administration study identified.
Peptide Partners maps combination logic, interaction data, and cycle structure for experienced self-experimenters. Every article draws from published research. Where data is absent, we say so.
Independent reference. No supplements sold. No protocols endorsed. Information presented for research and planning purposes only.